Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995

L. T.W. De Jong-van Den Berg, H. E.K. De Walle, K. M. Van Der Pal-de Bruin, S. E. Buitendijk, M. C. Cornel

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective: In November 1993, Dutch health authorities advised that women planning a pregnancy should take folic acid in the periconceptional period to reduce the risk of fetal neural tube defects. In the autumn of 1995 a national campaign was organized to inform women and health care professionals in a systematic way. Methods: We assessed the awareness and behaviour of women at their first or second antenatal visit in two surveys in the spring of 1994 and the autumn of 1995, in order to evaluate the impact of non-systematic information during that period, and to collect baseline data to evaluate the effect of the national folic acid campaign. The two surveys were carried out in the north and the west of The Netherlands. Results: The proportion of women who had heard of folic acid increased from 28% to 78%. The proportion that used folic acid during any period in pregnancy increased from 7.8% to 26%. The proportion that took folic acid tablets during the whole of the recommended period increased from 0.8 to 4.4%. In the group of women wits did not take folic acid, the proportion who did 'not like to use anything during pregnancy' decreased, as did the proportion who did 'not think it is useful'. Conclusion: In The Netherlands, non-systematic information about periconceptional folic acid use has already led to significant changes in awareness and behaviour before the start of the national folic acid campaign.

Original languageEnglish
Pages (from-to)329-331
Number of pages3
JournalEuropean Journal of Clinical Pharmacology
Volume54
Issue number4
DOIs
Publication statusPublished - 27 Jul 1998
Externally publishedYes

Cite this

De Jong-van Den Berg, L. T.W. ; De Walle, H. E.K. ; Van Der Pal-de Bruin, K. M. ; Buitendijk, S. E. ; Cornel, M. C. / Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995. In: European Journal of Clinical Pharmacology. 1998 ; Vol. 54, No. 4. pp. 329-331.
@article{cbbbbf60e45b4701bbe6be8ced3fe10e,
title = "Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995",
abstract = "Objective: In November 1993, Dutch health authorities advised that women planning a pregnancy should take folic acid in the periconceptional period to reduce the risk of fetal neural tube defects. In the autumn of 1995 a national campaign was organized to inform women and health care professionals in a systematic way. Methods: We assessed the awareness and behaviour of women at their first or second antenatal visit in two surveys in the spring of 1994 and the autumn of 1995, in order to evaluate the impact of non-systematic information during that period, and to collect baseline data to evaluate the effect of the national folic acid campaign. The two surveys were carried out in the north and the west of The Netherlands. Results: The proportion of women who had heard of folic acid increased from 28{\%} to 78{\%}. The proportion that used folic acid during any period in pregnancy increased from 7.8{\%} to 26{\%}. The proportion that took folic acid tablets during the whole of the recommended period increased from 0.8 to 4.4{\%}. In the group of women wits did not take folic acid, the proportion who did 'not like to use anything during pregnancy' decreased, as did the proportion who did 'not think it is useful'. Conclusion: In The Netherlands, non-systematic information about periconceptional folic acid use has already led to significant changes in awareness and behaviour before the start of the national folic acid campaign.",
keywords = "Awareness, Behaviour, Folic acid, Neural tube defects, Public health education",
author = "{De Jong-van Den Berg}, {L. T.W.} and {De Walle}, {H. E.K.} and {Van Der Pal-de Bruin}, {K. M.} and Buitendijk, {S. E.} and Cornel, {M. C.}",
year = "1998",
month = "7",
day = "27",
doi = "10.1007/s002280050468",
language = "English",
volume = "54",
pages = "329--331",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "4",

}

Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995. / De Jong-van Den Berg, L. T.W.; De Walle, H. E.K.; Van Der Pal-de Bruin, K. M.; Buitendijk, S. E.; Cornel, M. C.

In: European Journal of Clinical Pharmacology, Vol. 54, No. 4, 27.07.1998, p. 329-331.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995

AU - De Jong-van Den Berg, L. T.W.

AU - De Walle, H. E.K.

AU - Van Der Pal-de Bruin, K. M.

AU - Buitendijk, S. E.

AU - Cornel, M. C.

PY - 1998/7/27

Y1 - 1998/7/27

N2 - Objective: In November 1993, Dutch health authorities advised that women planning a pregnancy should take folic acid in the periconceptional period to reduce the risk of fetal neural tube defects. In the autumn of 1995 a national campaign was organized to inform women and health care professionals in a systematic way. Methods: We assessed the awareness and behaviour of women at their first or second antenatal visit in two surveys in the spring of 1994 and the autumn of 1995, in order to evaluate the impact of non-systematic information during that period, and to collect baseline data to evaluate the effect of the national folic acid campaign. The two surveys were carried out in the north and the west of The Netherlands. Results: The proportion of women who had heard of folic acid increased from 28% to 78%. The proportion that used folic acid during any period in pregnancy increased from 7.8% to 26%. The proportion that took folic acid tablets during the whole of the recommended period increased from 0.8 to 4.4%. In the group of women wits did not take folic acid, the proportion who did 'not like to use anything during pregnancy' decreased, as did the proportion who did 'not think it is useful'. Conclusion: In The Netherlands, non-systematic information about periconceptional folic acid use has already led to significant changes in awareness and behaviour before the start of the national folic acid campaign.

AB - Objective: In November 1993, Dutch health authorities advised that women planning a pregnancy should take folic acid in the periconceptional period to reduce the risk of fetal neural tube defects. In the autumn of 1995 a national campaign was organized to inform women and health care professionals in a systematic way. Methods: We assessed the awareness and behaviour of women at their first or second antenatal visit in two surveys in the spring of 1994 and the autumn of 1995, in order to evaluate the impact of non-systematic information during that period, and to collect baseline data to evaluate the effect of the national folic acid campaign. The two surveys were carried out in the north and the west of The Netherlands. Results: The proportion of women who had heard of folic acid increased from 28% to 78%. The proportion that used folic acid during any period in pregnancy increased from 7.8% to 26%. The proportion that took folic acid tablets during the whole of the recommended period increased from 0.8 to 4.4%. In the group of women wits did not take folic acid, the proportion who did 'not like to use anything during pregnancy' decreased, as did the proportion who did 'not think it is useful'. Conclusion: In The Netherlands, non-systematic information about periconceptional folic acid use has already led to significant changes in awareness and behaviour before the start of the national folic acid campaign.

KW - Awareness

KW - Behaviour

KW - Folic acid

KW - Neural tube defects

KW - Public health education

UR - http://www.scopus.com/inward/record.url?scp=0031817332&partnerID=8YFLogxK

U2 - 10.1007/s002280050468

DO - 10.1007/s002280050468

M3 - Article

VL - 54

SP - 329

EP - 331

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 4

ER -